Sudhir Bhatia’s Post

View profile for Sudhir Bhatia, graphic

CEO bei MICROBOSS Nanomedicine GmbH

 #Influenzavirus H5N1: Next pandemic outbreak??   Today American media are reporting 71 persons under monitoring for H5N1. I wrote a few days that USA Govt has learned from SARS CoV-2 pandemic outbreak nothing and now they are going to do the same mistakes and telling us same old PR stories as they are going to use the similarly type of solutions of questionable stock listed companies. This outbreak can have a big impact on election and its outcome.  Mr. #Trump as next president will be welcomed through the next H5N1 virus outbreak, which will not be any fun like SARS CoV-2 outbreak. Next president may need 4 years or more to bring this pandemic outbreak under control, if this happens. Again, they are talking about questionable vaccines, but they must show any effective vaccine in human beings as well as animals because regions like matrix, hemagglutinin or neuraminidase of this virus do not provide the perfect immunity. My suggestion is that one must use boosting of immune system and preventive measurements to reduce the virus load in the population along providing the immune system a chance to get immunized against the natural H5N1 strain. This is very difficult task! The food security is going to be another VERY big challenge! Genekampowermolecule has both properties to be used as therapeutic as well as prevention molecule without any side effects, hence it can help to reduce the infection in a population. Genekam has very effective molecular tests for detection of H5N1. These can provide the time needed to develop the effective prevention and therapeutic options. Genekam has a number of therapeutic solutions against H5N1 e.g. real human antibodies and many small molecules.   #Washington #CNBC #ARD #ZDF #Texas #BBC #Foxnews https://lnkd.in/e2avKMdY

Seventy Americans in one state being monitored for bird flu

Seventy Americans in one state being monitored for bird flu

dailymail.co.uk

To view or add a comment, sign in

Explore topics